Name Development Level Target Family
Name Description
denosumab A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
denosumab